May 09, 2016 at 15:18 | Source: CNBC-TV18
Joint inspections with eight other regulators carried at six of Ranbaxys laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
May 05, 2016 at 20:47 | Source: CNBC-TV18
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
Apr 04, 2016 at 19:50 | Source: PTI
The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd forallegedly selling substandard drugs in India.
Mar 07, 2016 at 12:26 | Source: Reuters
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.
Jan 22, 2016 at 19:05 | Source: PTI
Last year in September, Sun Pharma and Strides Shasun (then Strides Arcolab) had inked a pact related to Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India.
Oct 28, 2015 at 20:15 | Source: PTI
As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Oct 09, 2015 at 08:36 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Limited (Ranbaxy) in November 2014 in a US District Court against U.S. Food and Drug Administration (FDA).
Sep 24, 2015 at 16:42 | Source: CNBC-TV18
Prakash Diwan of prakashdiwan.in is of the view that Lupin may test Rs 2600-2700.
Sep 24, 2015 at 13:25 | Source: CNBC-TV18
Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.